Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $3.80

Daily Change: +$0.03 / 0.79%

Daily Range: $3.78 - $3.93

Market Cap: $322,675,808

Daily Volume: 11,820

Performance Metrics

1 Week: 5.60%

1 Month: 13.55%

3 Months: 79.52%

6 Months: 2.72%

1 Year: -52.88%

YTD: -2.58%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country:

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

Ethan Allen Interiors Inc. (ETD)

Planet Image International Limited (YIBO)

Winnebago Industries, Inc. (WGO)